JD Health starts roadshow for $3.5bn IPO

By Jonathan Breen
25 Nov 2020

JD Health International has hit the road with an up-to HK$27bn ($3.5bn) Hong Kong IPO, set to be the largest primary listing in the city this year.

The issuer, a subsidiary of e-commerce company JD.com, operates a health management service that includes China’s largest online healthcare platform and online retail pharmacy.

Sponsors Bank of America, Haitong International and UBS kicked off the deal on Wednesday morning in Hong Kong, according to a source familiar with ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial